DNA-protective activity of new ribonucleotide reductase inhibitors

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3437-3440

  Rauko, Peter ^a   Romanova, Darina ^a   Miadokova, Eva ^b   Macakova, Kvetoslava ^b   Novotny, Ladislav ^a   Elford, Howard L ^c   Szekeres, Thomas ^d  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c Molecules for Health Inc   (United States)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

DNA damage; DNA protection; Hydrogen peroxide; Plasmid DNA; Ribonucleotide reductase inhibitors

Indexed keywords

3,4 DIHYDROXYBENZOHYDROXAMIC ACID; AMIDOX; ENZYME INHIBITOR; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYUREA; PLASMID DNA; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DNA STRUCTURE; DRUG MECHANISM; ELECTROPHORESIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BENZAMIDINES; DNA DAMAGE; DNA, SUPERHELICAL; ENZYME INHIBITORS; FREE RADICALS; HYDROGEN PEROXIDE; HYDROXAMIC ACIDS; HYDROXYUREA; OXIMES; PLASMIDS; RIBONUCLEOTIDE REDUCTASES;

EID: 0030730939     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Elford HL Freese M, Passamani E and Morris HP: Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chem 245: 5228-5233, 1470.
2. Takeda E and Weber G: Role of ribonucleotide reductase in the expression of the neoplastic program. Life Sci 28: 1007-1014, 1981.
3. Schitsky RL, Williams SF, Ultmann JE and Watson S: Sequential hydroxyurea/ cytarabine chemotherapy for refractory non-Hodgkin's lymphoma. J Clin Oncol 5: 419-425, 1987.
4. Elford HL, Wampler GL and van't Riet B: New ribonucleotide reductase inhibitors with antineoplastic activity. Cancer Res 39: 844-851, 1979
5. Elford HL, van't Riet B, Wampler GL, Lin AL and Elford RM: Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents. Adv Enzyme Regul 19: 151-168, 1981.
6. Tihan T, Elford HL and Cory JG: Studies on the mechanism of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime Advan Enzyme Regul 31: 71-83, 1991.
7. Veale D, Carmichael J, Cantwell BMJ, Elford HL, Blackie R, Kerr DJ, Kaye SB and Harris AL: A phase I and pharmacokinetic study of didox: A ribonucleotide reductase inhibitor. Brit J Cancer 58: 70-73, 1988
8. Carmichael J, Cantwell BMJ, Mannix KA, Veale D, Elford HL, Blackie R, Kerr DJ, Kaye SB and Harris AL: A phase I and pharmacokinetic study of didox administrated by 36 hour infusion. Brit J Cancer 61: 447-450, 1990.
9. Rubens RD, Kaye SB, Soukop M, Williams CJ, Bramton MH, Harris MH and Harris AL: Phase II trial of didox in advanced breast cancer. Brit J Cancer 64: 1187-1188, 1991.
10. Szekeres T, Gharehbaghi K, Fritzer M, Woody M, Srivastava A, van't Riet B, Jayaram HN and Elford HL: Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase. Cancer Chemother Pharmacol 34: 63-66, 1994.
11. Szekeres T, Fritzer M, Stobl H, Gharehbaghi K, Findening G, Elford HL, Lhotka Ch, Schoen H and Jayaram HJ: Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells. Blood 84: 4316-4321, 1994.
12. Szekeres T, Vielnascher E, Novotny L, Vachalkova A, Fritzer M, Findenig G, Gobi R, Elford HL and Goldenberg H: Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase. Eur J Clin Chem Clin Biochem 33: 785-789, 1995.
13. Blazek ER and Peak MJ: The role of hydroxyl radical guenching in the protection by acetate and ethylenediamminetetraacetate of supercoiled plasmid DNA from ionizing radiation-induced strand breakage. Int J Radiat Biol 53: 237-247, 1988.
14. Blazek ER, Peak JG and Peak MJ: Singlet oxygen induces frank strand breaks as well as alkali- and piperidine-labile sites in supercoiled plasmid DNA. Photochem Photobiol 49: 607-613, 1989.
15. Sugiura Y, Uesawa Y, Takahashi Y, Kuwahara J, Golik J and Doyle TW: Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. Proc Natl Acad Sci USA 86: 7672-7676, 1989.
16. Herman TS, Teicher BA, Chan V, Collins LS and Abrams MJ: Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 16: 443-449, 1989.
17. Teicher BA, Herman TS and Kaufmann ME: Platinum complexes of triaminotriphenylmethanes: Interaction with DNA and radiosensitization. Cancer Lett 47: 217-228, 1989.
18. Teicher BA, Herman TS and Kaufmann ME: Interaction of platinum(II) tetrachlorodianion (fast black) 2 with superhelical DNA and with radiation in vitro and in vivo. Radiat. Res 119: 134-144, 1989.
19. Rauko P, Hrubisko M and Hanusovska E: Electrophoretic analysis of DNA modifications induced by cis- and trans-diamminedichloroplatinum(II) during heatdenaturation of conformation isomers of pBR322 DNA. Neoplasma 37: 131-138, 1990.
20. Rauko P, Novotny L and Balazova E: Potentiation of cis-DDP and pyridoxal effect on isolated DNA during simultaneous application. Neoplasma 40: 283-288, 1993.
21. Rauko P, Novotny L and Balazova E: DNA breakage and inactivation resulting from hydroxylamine and/or cis-diamminedichloroplatinum(II) interactions with plasmid DNA. Int J Biochem 25: 1475-1481, 1993.
22. Imlay JA, Chin SM and Linn S: Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science (Washington D.C.) 240: 640-642, 1988.
23. Tovokuni S and Sagripanti JL: Induction of oxidative single- and double-strand breaks in DNA by ferric citrate. Free Radical Biol Med 15: 117-123, 1993.
24. Simic MG: DNA markers of oxidative processes in vivo: Relevance to carcinogenesis and anticarcinogenesis. Cancer Res 54 (Suppl.). 1918s-1923s, 1994.
25. Maniatis T Fritsch EF and Sambrook J (Eds.): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982.
26. Skog S, Heiden T, Eriksson S, Wallstrom B and Tribukait B: Hydroxyurea induced cell death in human T Iymphoma cells as related to imbalance in DNA protein cycle and deoxyribonucleotide pools and DNA strand breaks. Anti-Cancer Drugs 3: 379-386, 1992.
27. Carter SK: Adriamycin - A review. J Natl Inst 55: 1265-1274, 1975.
28. Sato S, Iwaizumi M, Handak K and Tamura Y: Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin and carboquone in NAD(P)H-microsome system. Gann 68: 603-608, 1977.
29. Elford HL, van't Riet B, Mikhail EA and Zweier JL: Free radical scavengers trimidox and didox protect against cardiac toxicity and improve antitumor activity of antracyclines. Proc Am Ass Cancer Res 36: 296, 1996 (Abstract)
30. Elford HL, van't Riet B, Novotny L, Mikhail E and Zweier JL: Ribonucleotide reductase inhibitors Didox and Trimidox enhance antitumor activity of antracyclines. Cytoxan and Pt compounds and protect against anthracycline cardiac toxicity Proc Am Ass Cancer Res 36: 294, 1996 (Abstract).